Prof. Dr. Raja Atreya

Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

Seroprevalence of SARS-CoV2 in IBD patients treated with biologic therapy (2021) Berte R, Mazza S, Stefanucci MR, Noviello D, Costa S, Ciafardini C, Mileti E, et al. Journal article Can Serum Proteomic Profiling Annunciate Individual Disease Progression in Newly Diagnosed Inflammatory Bowel Disease Patients? (2021) Atreya R, Neurath M Journal article Real World Evidence on the effectiveness of ustekinumab in Crohn's Disease: Induction phase results from the prospective, observational RUN-CD Study (2021) Bokemeyer B, Plachta-Danielzik S, Di Giuseppe R, Mohl W, Teich N, Hoffstadt M, Schweitzer A, et al. Conference contribution Role of the IL23/IL17 Pathway in Crohn’s Disease (2021) Schmitt H, Neurath M, Atreya R Journal article, Review article CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-γ Producing Innate Lymphoid CelIs and Protects From Experimental Colitis (2021) Kang L, Schmalzl A, Leupold T, Gonzalez-Acera M, Atreya R, Neurath M, Becker C, Wirtz S Journal article The JAK1/3 Inhibitor to Tofacitinib Suppresses T Cell Homing and Activation in Chronic Intestinal Inflammation (2021) Gerlach K, Lechner K, Popp V, Offensperger L, Zundler S, Wiendl M, Becker E, et al. Journal article Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling (2021) Patankar JV, Lehmann M, Kühl AA, Atreya R, Becker C, Gonzalez-Acera M, Schmitt H, et al. Journal article Molecular Endoscopic Imaging in Cancer (2021) Rath T, Neurath M, Atreya R Authored book Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study (2021) Goessens L, Colombel JF, Outtier A, Ferrante M, Sabino J, Judge C, Saeidi R, et al. Journal article Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn’s disease patient upon infliximab-induced lupus-like syndrome (2021) Hirschmann S, Fischer S, Klenske E, Dechant K, Distler J, Treutlein C, Neurath M, Atreya R Journal article